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Abstract
Purpose of Review—Methods to isolate endothelial cells from murine and human pluripotent 
stem cells continue to evolve and increasingly diverse endothelial cell populations have been 
generated. This review provides an update of key papers published within the past year that report 
on some of those advances.
Recent findings—Cooperative interactions among microRNA (miRNA), transcription factors, 
and some downstream interacting proteins have been reported to enhance endothelial specification 
from embryonic stem cells (ESC) and induced pluripotent stem cells (iPSC). Endothelial cell 
differentiation can also be modulated by various growth factor additions, Notch pathway 
activation or inhibition, and modulation of the microenvironment of the differentiating ESC and 
iPSC. Functionality of the derived endothelium has been demonstrated by a variety of in vitro and 
in vivo assays. Finally two recent reports have identified endothelial progenitor populations with 
robust proliferative potential.
Summary—Progress in differentiating endothelial cells from ESC and iPSC has been made. The 
recent report of formation of endothelial colony forming cells from human ESC and iPSC 
provides a protocol that can generate clinically relevant numbers of cells for human cell therapy.
Keywords
Embryonic stem cells; Induced pluripotent stem cells; Endothelial cells; Endothelial colony 
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Introduction
Endothelial cells (EC) line the blood vessels that are diversified from simple capillaries 
formed by single EC into large multi-layered and multi-cellular conduit vessels in the 
arterial, venous, and lymphatic systems. A greater appreciation of the tissue heterogeneity of 
EC within specific tissues and organs has been achieved through some seminal publications 
that highlight specific angiocrine factors in modulating tissue functions [1–3]. As the 
transcriptional profiles and cell and tissue specific patterns of gene expression regulating 
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cell function become more clarified, targeted profiles for tissue specific EC phenotypes have 
become of interest for scientists generating EC from murine and human embryonic stem 
cells (ESC) and induced pluripotent stem cells (iPSC). Several recent reviews have 
highlighted potential heterogeneities in the EC derived from ESC and iPSC [4–7]. This 
review will focus on some recent advances in generating EC from murine and human ESC 
and iPSC published within the past 12 months.
Studies with murine ESC or iPSC
In general, EC are derived from differentiating ESC and iPSC via 3 primary methods [7]. 
First, ESC and iPSC can be differentiated in conditions that promote self-aggregation of the 
cells into three dimensional embryoid bodies (EB) in a suspension culture. Numerous 
lineages of cells will emerge within the EB which spontaneously undergo differentiation 
into the 3 germ layers: ectoderm, endoderm, and mesoderm. It is from the mesoderm subset 
that both hematopoietic and EC emerge. The EC self-organize into vascular structures 
within the EB. Addition of a variety of growth factors will promote enhanced EC 
differentiation within the EB. In a second method, differentiating ESC and iPSC are co-
cultured with some type of stromal cell to promote EC lineage differentiation from the 
mesoderm. Murine calvarial mesenchymal cells called OP9 cells are widely used to promote 
differentiation and facilitate emergence of cardiac, hematopoietic, endothelial, and other 
lineages. Finally, some investigators prefer differentiating the ESC and iPSC in 2 dimension 
culture on tissue culture plates coated with protein substrates (Matrigel, fibronectin, gelatin, 
or other proteins) using specific culture mediums with sequentially added recombinant 
growth factors. No matter which of the 3 methods are chosen, numerous lineages of cells 
emerge from the proliferating and differentiating ESC and iPSC and use of growth factors, 
growth factor inhibitors, small molecules, and neutralizing antibodies can be used to 
promote enrichment of the lineage of choice. In general, use of monoclonal antibodies to 
identify specific cell surface molecules or genetic tagging of the ESC or iPSC with lineage 
specific fluorescent reporter systems are required for each of the 3 methods of differentiation 
to identify the cell lineage of choice and to enrich the cells using some form of cell sorting 
and isolation [7]. Key steps in the emergence of the murine EC are the early expression of 
Flk1 in Brachyury (BRY) expressing mesoderm cells that requires activing A/nodal 
signaling. Activation of bone morphogenetic protein 4 (BMP4) signaling further enhances 
formation of the mesoderm subset giving rise to blood and EC. Subsequent addition of 
numerous growth factors such as vascular endothelial growth factor A (VEGFA), fibroblast 
growth factor 2 (FGF2), insulin-like growth factor-1 (IGF-1), epidermal growth factor 
(EGF), and placental growth factor (PlGF) all further promote EC proliferation, 
differentiation and eventual maturation during the in vitro culture.
While most reports have identified the mesoderm germ layer as the source of endothelial 
precursors, Goldman et al. [8] have recently presented evidence that some EC derived from 
differentiated murine and human ESC are derived from the endoderm lineage. Using 
established protocols for deriving enriched endoderm precursors in ESC-derived EBs, 
hepatic precursors were identified and characterized and certain subsets were shown to give 
rise to EC. Subsequent examination of human fetal liver specimens (7 – 7.5 week-old fetal 
samples) provided confirmation that some liver EC co-express endothelial and hepatic 
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markers. A variety of in vitro and in vivo vascular functional analyses confirmed that the 
endoderm-derived EC display mature endothelial functions. Validation of the role of 
endoderm as a source for some liver EC was provided via the use of dual-reporter transgenic 
mice ESC differentiation cultures and use of a mouse endoderm lineage-tracing model that 
confirmed marking of fetal liver hepatoblasts and some liver EC. Whether or not these liver 
EC are restricted to formation of sinusoidal endothelial cells remains to be determined, but 
these findings suggest one potential mechanism to generate tissue specific EC.
Some important transcription factors that promote EC emergence from mesoderm precursors 
have been identified recently. Cha et al. [9] have reported that an isoform of the transcription 
elongation factor TFIIS called Tcea3, is highly enriched in mouse ESC and negatively 
regulates Activin A/Nodal signaling. When Tcea3 transcripts were diminished using a 
shRNA plasmid in murine ESC, the ESC displayed enhanced expression of mesoderm 
markers including BRY, VEGFA, and VEGFC with loss of expression of pluripotiency gene 
transcripts. Consistent with enhanced mesoderm formation, greater numbers of EC with 
enhanced tube formation were observed when the murine ESC with diminished Tcea3 
transcripts were cultured in vitro. These studies suggest that Tcea3 plays an important role in 
EC differentiation from murine ESC via modulation of Activan A/Nodal signaling.
Certain transcription factors appear to be critical for differentiation of EC from murine ESC. 
Er71/Etv2, a member of the E-twenty six (ETS) transcription factor family has been 
reported to be necessary for mesoderm specification giving rise to both blood and EC 
lineages during murine, zebrafish, and Xenopus development [10,11]. Er71/Etv2 is known to 
directly bind to numerous genes that are critical for blood and EC lineage development 
including Flk1, vascular endothelial-cadherin (VE-cad), stem cell leukemia (Scl), and limb 
domain only 2 (Lmo2). Kim et al. [12] have recently identified a transcription factor Ovo-
like zinc finger 2 (OVOL2), a C2H2 zinc finger protein, as a novel interacting protein for 
Er71/Etv2. They reported that OVOL2 and ER71 co-localized in the nucleus of 
hematopoietic cells upon immunohistochemical staining with antibodies. While OVOL2 
alone failed to activate the Flk1 promoter, it significantly enhanced ER71-mediated Flk1 
promoter activation. Co-expression of ER71 and OVOL2 in differentiating murine ESC led 
to a significant increase in endothelial and hematopoietic cell production. When Ovol2 
transcripts were diminished using a short-hairpin RNA-mediated inhibition approach, 
significant loss of ESC differentiation into blood and EC was observed. They concluded that 
OVOL2 is an interacting transcription factor that directly binds to ER71 and is critical for 
the differentiation of blood and EC from murine ESC.
Shi et al. [13] have reported that the GATA2 transcription factor is co-expressed and directly 
interacts with ER71 in EC and hematopoietic cells of murine embryos. Increased co-
expression of GATA2 significantly augments ER71 in the production of endothelial and 
blood cells from differentiating murine ESC. Evidence is presented that ER71 and GATA2 
directly bind to the Spi1 transcription factor gene both in vitro and in vivo in early murine 
embryogenesis and this pathway may be critical for regulating mesoderm differentiation into 
endothelial and hematopoietic cells.
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Vereide et al. [14] performed a screening of various candidate molecules known to be 
important for hematopoietic differentiation via use of a doxycycline inducible cassettes in 
murine ESC, fetal liver cells, and/or fibroblast cells. Six transcription factors including 
Gata2, Lmo2, Mycn, Pitx2, Sox17, and Tal1 were demonstrated to impose a program in 
transfected cells that restricted them in a proliferative state with hemangioblastic potential 
that could be released upon removal of the doxycycline induction and EC, blood cells, and 
some smooth muscle cells emerged. A central role for FGF2 in stimulating the “expandable 
hemangioblasts” to proliferate more efficiently and to demonstrate greater migratory 
behavior with a flatter morphology (all evidence of a less differentiated state). The authors 
conclude that these results imply that it is possible to identify and control the state of various 
lineage progenitor cells and this ability may permit identification of the molecules required 
to trap, expand, and study progenitors in lineages currently poorly maintained in culture.
EC lineage emergence from differentiated iPSC may also be regulated by specific micro-
RNA (miR). Di Bernardini et al. [15] reported that miR-21 was one of the most 
overrepresented miR expressed as murine ESC were differentiated into EC. When miR-21 
was overexpressed in differentiating ESC, numerous endothelial lineage markers were 
increased along with increases in capillary tube-like structures in vitro and greater 
vascularization in Matrigel plugs implanted in vivo. The authors confirmed a role for 
activation of the Akt signaling pathway in mediating the miR-21 induced effects to promote 
endothelial differentiation. Chen et al. [16] reported that miR-199 is increased in a step-wise 
fashion as murine ESC differentiate into EC. MiR-199 was observed to target and suppress 
expression of the Notch ligand Jagged 1 (JAG1) and this resulted in an increase in VEGF 
transcription and secretion in a STAT3 dependent fashion. Use of short-hairpin RNA-
mediated knockdown of JAG1 expression ablated the effect of miR-199 on EC 
differentiation. Murine ESC-derived EC transfected with miR-199 demonstrated increased 
capillary tube-like formation in vitro and in vivo vascularization in implanted Matrigel 
plugs. Of interest, overexpression of miR-199 inhibited differentiation of vascular smooth 
muscle cells from differentiating ESC and led the authors to conclude that miR-199 may 
serve as a regulator of the phenotypic switch controlling EC versus smooth muscle cell 
differentiation.
As an example of the use of iPSC differentiation to serve as a tool for understanding a 
clinical condition, Gu et al. [17] examined whether iPSC-derived EC derived from subjects 
with diet-induced obesity (DIO) would exhibit signs of endothelial dysfunction (as is known 
to occur in the obese subjects) or would be reprogrammed and not display endothelial 
dysfunction. The iPSC-derived EC generated from DIO mice displayed significantly less 
migratory activity, proliferation, and decreased capillary tube-like formation in vitro; all 
signs of EC dysfunction. DIO iPSC-derived EC injected into the muscle of animals that had 
undergone acute ischemic injury induction failed to improve reperfusion compared to wild-
type iPSC-derived EC. Of interest, co-infusion of pravastatin into the site of hindlimb 
ischemia along with the DIO iPSC-derived EC led to a significant improvement in 
reperfusion in a nitric oxide dependent fashion. The authors concluded that this is the first 
evidence that DIO iPSC-derived EC display endothelial dysfunction and raises questions 
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about use of iPSC derivation from obese human subjects for generating cell therapies to treat 
EC dysfunction in these subjects.
Studies with human ESC or iPSC
Culture methods to differentiate EC from human ESC or iPSC generally follow the 3 
methods described above. However, recent advances in some culture methods have provided 
for more enriched populations of EC or combinations of desired cell lineages with EC to 
promote tissue recovery in various animal model systems. Zhang et al. (Zhang S et al. 
Biomaterials 2014) reported that human iPSC can be plated as a single cell suspension in a 
3D fibrin scaffold with up to 45% of the differentiated iPSC displaying EC markers at day 
14 of culture. Upon purification, more than 95% of cultured cells displayed EC markers for 
at least one month. The authors conclude that this method for deriving EC is highly efficient. 
The exact ratio of iPSC:EC was not reported for this protocol and the overall number of EC 
produced during the one month culture was not discussed; two important variables when 
contemplating development of protocols for generating cells for human cell therapy.
Masumoto et al. [18] developed a culture system to simultaneously generate 
cardiomyocytes, EC, and vascular mural cells from human iPSC over a 18 day period. The 
heterogenous differentiated population of cells is then cultured on temperature-responsive 
adhesive culture plates that permit development of tissue sheets that can be overlaid to 
produce cardiac tissue-like multi-layered structures. Transplantation of the “cardiac tissue 
sheets” into hearts of athymic nude rats that had undergone experimental sub-acute 
myocardial infarction led to significant improvements in cardiac function with engraftment 
of human cardiomyocytes in >40% of the transplanted animals. The authors conclude this 
protocol may be useful to apply for human cardiac regenerative therapy. Skelton et al. [19] 
developed a cell surface marker detection system to define cell lineage relationships during 
cardiomyocyte differentiation from human iPSC. Specific cell surface markers were 
identified that permitted isolation and discrimination of EC from cardiac lineage specified 
cells. It is proposed that use of the identified markers will permit a starting approach to map 
early human cardiogenesis.
Orlova et al. [20] developed an iPSC differentiation protocol for the simultaneous derivation 
of EC and pericytes. On day 10 of iPSC differentiation, from 10–30% of cells displayed 
CD31 and/or CD34 expression (EC markers) while 30% expressed platelet derived growth 
factor receptor beta (mesenchymal marker). The EC and pericytes displayed stable cell 
surface markers and lineage functions; for example, human iPSC-derived EC engrafted in 
zebrafish embryos and integrated into the embryonic zebrafish vasculature. Park et al. [21] 
also developed a iPSC-derived EB system for generating cells that displayed EC/pericyte 
markers they termed vascular progenitor (VP) cells. The VP cells developed were capable of 
engrafting into the injured retinal capillaries of mice that had been subjected to high 
intraocular pressure to induce retinal ischemia/reperfusion injury and persisted up to 45 days 
in vivo. Surprisingly, the EC generated from iPSC derived from cord blood CD34 
expressing cells were superior to EC generated from iPSC derived from fibroblast cells or 
EC generated from ESC in homing, engrafting, and persisting in the injured retina.
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Several recent publications have begun to more closely assess the functions of EC derived 
from iPSC or ESC to primary EC populations in human subjects. Reed et al. [22] reported 
that human umbilical vein EC (HUVEC), blood outgrowth EC (BOEC), and iPSC-derived 
EC all displayed both toll-like receptor-4 (TLR4) and nucleotide-binding oligomerization 
domain-containing protein-1 (NOD1) molecules that are critical for sensing and binding 
gram negative bacterial organisms. In contrast, ESC-derived EC fail to express TRL4, but 
do bind and respond to gram negative bacteria via expressed NOD1. These data suggest that 
ESC-derived EC may escape unwanted TRL4 mediated inflammatory situations and this 
may represent a potential advantage over other EC sources. Reed et al. [23] also reported 
that HUVEC, BOEC, human aortic EC (HAEC), and human lung microvascular EC 
(HMVEC) all secreted high and comparable levels of the vasoconstrictor endothelin-1 and 
the cardio protective hormone prostacyclin; ESC-derived EC failed to express either of these 
molecules. Culture of the EC under shear stress caused the BOEC and HAEC to elongate 
and align to the direction of the shear stress, while ESC-derived EC failed to respond to 
shear stress with any changes in morphology. These results suggest that BOEC (derived as 
circulating cells in the peripheral blood) are more similar to HUVEC, HAEC, and HMVEC 
than the ESC-derived EC. Since other groups have reported that ESC-derived EC may 
respond to shear stress with changes in morphology [24,25], these results also raise the 
question as to whether the EC derived from ESC may be heterogenous in their functional 
properties depending on the ESC line or conditions of differentiation.
Sahara et al. [26] have recently reported derivation of an endothelial progenitor (EP) 
population of cells displaying expression of CD31, CD34, and KDR, but not CD14 in a 
multi-step 14 day differentiation protocol from an endothelial specific VE-cad promoter 
reporter ESC line. The iPSC:EC ratio of 1:20 was reported to be a significant improvement 
over prior publications. The EP population (identified on day 6–7 of the protocol after 2 
differentiation steps) outperformed the more mature EC generated during step 3 of the 
differentiation protocol (days 7–14) with respect to the number of blood vessels formed in 
implanted Matrigel plugs and the EP persisted in the host immunodeficient mice for 3 
months without tumor formation. The authors conclude that the ESC-derived EP are more 
readily produced and display superior vessel forming ability compared to more mature EC 
and may be an attractive cell population for revascularization strategies in human subjects.
Prasain et al. [27] report the most significant advance for the field of scientists interested in 
generating EC from human ESC or iPSC. They have developed a novel protocol that relies 
upon identification of a Neuropilin-1 (NRP-1) expressing subset of EC co-expressing CD31 
and CD144 that display functional properties similar to umbilical cord blood endothelial 
colony forming cells (UCB-ECFC) with high clonal proliferative potential and robust in 
vivo vessel-forming ability. The ESC-NRP-1+CD31+ECFC and iPSC-NRP-1+CD31+ECFC 
maintained a stable endothelial phenotype and function and did not undergo replicative 
senescence for 18 passages in vitro. Given the high rate of proliferation, the iPSC:EC ratio 
was identified as 1:1 × 108; by far the most robust generation of functional EC that has been 
reported. These EC engrafted and formed functional human vessels in immunodeficient 
mice for > 6 months. Furthermore, the iPSC-NRP-1+CD31+ECFC rescued the avascular 
regions and blunted the neovascularization observed in vehicle treated mice that had 
undergone oxygen-induced retinopathy induction. Finally, the iPSC-NRP-1+CD31+ECFC 
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significantly rescued blood flow to the ischemic hindlimb of mice that had undergone 
femoral excision to a degree similar to UCB-ECFC infusion. These data indicate that there is 
a unique population of ESC-NRP-1+CD31+ECFC and iPSC-NRP-1+CD31+ECFC that can 
be identified using specific differentiation conditions that can provide clinically relevant 
numbers of highly functional EC that may be a useful cell therapy to employ in patients that 
display vascular dysfunction.
Conclusion
Numerous advances in the derivation, expansion, and functional analysis of EC derived 
from ESC and iPSC have been made in the past year. This overview has identified some of 
those recent advances. It is apparent that it is now feasible to generate clinically relevant 
numbers of EC from ESC and iPSC to consider for use as a cell therapy in human subjects.
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Key points
• Endothelial cells can be derived from murine and human ESC and iPSC
• ESC- and iPSC-derived endothelial cells display many features of primary 
endothelial cells
• A novel protocol to generate clinically relevant numbers of endothelial cells 
from human ESC and iPSC has been reported
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